Results 271 to 280 of about 2,705,303 (297)
Some of the next articles are maybe not open access.
Invasive Fungal Infections in the ICU
Journal of Intensive Care Medicine, 2009Invasive fungal infections are major causes of morbidity and mortality in critically ill patients. Foremost among these is invasive candidiasis. In recent years, invasive aspergillosis (IA) and zygomycosis have emerged as major problems in susceptible, critically ill patients.
Shmuel, Shoham, Shilpa, Marwaha
openaire +2 more sources
Drugs, 2009
Invasive fungal infections (IFIs) are being increasingly recognized as a major threat in critically ill adult and paediatric patients. They can range widely in severity and can be life threatening in some patients. Candida and Aspergillus species are the most common causes of IFIs, but other yeasts and filamentous fungi are emerging pathogens.
openaire +3 more sources
Invasive fungal infections (IFIs) are being increasingly recognized as a major threat in critically ill adult and paediatric patients. They can range widely in severity and can be life threatening in some patients. Candida and Aspergillus species are the most common causes of IFIs, but other yeasts and filamentous fungi are emerging pathogens.
openaire +3 more sources
Clinical Experience in Invasive Fungal Infections
Clinical Drug Investigation, 2013Lung infections caused by invasive filamentous fungi are very rare conditions in AIDS, but must be considered in patients with profound immune suppression especially in the presence of additional risk factors, such as hematologic malignancies, corticosteroid therapy, neutropenia, and chemotherapy. The authors report a case of dual lung infection caused
Pacheco, P +4 more
openaire +3 more sources
Overview of Invasive Fungal Infections
2012The incidence of invasive fungal infections (IFIs) has seen a marked increase in the last two decades. This is especially evident among transplant recipients, patients suffering from AIDS, in addition to those in receipt of immunosuppressive therapy.
Nina L, Tuite, Katrina, Lacey
openaire +2 more sources
2016
Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3.
Lewis RE, Rogers PD
openaire +3 more sources
Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3.
Lewis RE, Rogers PD
openaire +3 more sources
Archives of Internal Medicine, 1983
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
Tailored Treatment of Invasive Fungal Infections
Future Microbiology, 2008The need to tailor antifungal treatment to local epidemiology and individual patient risk was a key theme of the 3rd Trends in Medical Mycology (TIMM-3) congress in Turin, Italy, 28–31 October 2007. Organized jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organisation for Research and ...
Johan, Maertens, Jenny, Bryan
openaire +2 more sources
Agents for treatment of invasive fungal infections
Otolaryngologic Clinics of North America, 2000The incidence of fungal infections continues to rise as the population of immunocompromised individuals increases. Despite the enlarging numbers of infections, there are only a few antifungal agents for treatment of deep-seated, invasive infections. These agents include amphotericin B, flucytosine, terbinafine, and several azoles.
B, Luna, R H, Drew, J R, Perfect
openaire +2 more sources
Invasive fungal infections in the pediatric population
Expert Review of Anti-infective Therapy, 2011Expert Rev. Anti Infect. Ther. 9(3), 275-278 (2011) Invasive fungal infections (IFIs) are increasing in incidence and constitute an important cause of morbidity and mortality in immunocompromised pediatric patient populations, including, but not limited to, preterm neonates, children and adolescents with hematologic malignancies, and those undergoing ...
Thomas, Lehrnbecher, Andreas H, Groll
openaire +2 more sources
Treatment Options for Invasive Fungal Infections
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006Clinicians face an increasing occurrence of invasive fungal infections. These are due not only to traditional yeast and mould species but also to rare pathogens that can be difficult to treat. The introduction of new agents has expanded the options for treating common and rare mycotic infections with antifungal efficacy at least equal, and safety far ...
openaire +2 more sources

